The expertise behind Do Bio’s technology is built on a strong foundation in the field of microfluidics. As the company has grown in recent years, the focus has shifted from purely single cell-based applications, to developing and supporting multiple microfluidics-based products for life sciences and pharmaceuticals.
The core value behind Do Bio’s products has always been centred on the ability to process, develop, and make biological discoveries, using the advantages of a microfluidic platform, without the need for microfluidic expertise.
The Nadia product family allows researchers to process a wide variety of biologicals, from cells, to proteins, to mRNA and lipids. Whether using droplets, particles, or homogenous fluids, researchers can develop novel microfluidic methodologies without compromising on reproducibility and scalability.
Do Bio expects to keep expanding their instruments, reagent kits, microfluidic chips, and cartridges, in line with its focus on empowering researchers to pursue their research goals.